SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Mel Spivak who wrote (29541)12/8/1999 7:30:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
MEDX was recommended by Steven Delco of Miller Tabak
207.235.5.146
on Bloomberg Television this morning
207.235.5.146



To: Mel Spivak who wrote (29541)12/15/1999 12:13:00 PM
From: Mel Spivak  Read Replies (1) | Respond to of 32384
 
Medx @ 20. Starting to gain momentum. Concensus on Yahoo bds of both MEDX & ABGX that MEDX should trade at 50% of ABGX. ABGX about 80.



To: Mel Spivak who wrote (29541)12/23/1999 11:55:00 AM
From: Mel Spivak  Respond to of 32384
 
OT on MEDX blastoff. Click on my post #29541 to find the detailed report on MEDX's tech and prospects. I always watch LGND. Now its MEDX that has momentum and getting stronger. Mel


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News